title: The proinflammatory cytokine high-mobility group box-1 mediates retinal neuropathy induced by diabetes.
abstract: To test the hypothesis that increased expression of proinflammatory cytokine high-mobility group box-1 (HMGB1) in epiretinal membranes and vitreous fluid from patients with proliferative diabetic retinopathy and in retinas of diabetic rats plays a pathogenetic role in mediating diabetes-induced retinal neuropathy. Retinas of 1-month diabetic rats and HMGB1 intravitreally injected normal rats were studied using Western blot analysis, RT-PCR and glutamate assay. In addition, we studied the effect of the HMGB1 inhibitor glycyrrhizin on diabetes-induced biochemical changes in the retina. Diabetes and intravitreal injection of HMGB1 in normal rats induced significant upregulation of HMGB1 protein and mRNA, activated extracellular signal-regulated kinase 1 and 2 (ERK1/2), cleaved caspase-3 and glutamate; and significant downregulation of synaptophysin, tyrosine hydroxylase, glutamine synthetase, and glyoxalase 1. Constant glycyrrhizin intake from the onset of diabetes did not affect the metabolic status of the diabetic rats, but it significantly attenuated diabetes-induced upregulation of HMGB1 protein and mRNA, activated ERK1/2, cleaved caspase-3, and glutamate. In the glycyrrhizin-fed diabetic rats, the decrease in synaptophysin, tyrosine hydroxylase, and glyoxalase 1 caused by diabetes was significantly attenuated. These findings suggest that early retinal neuropathy of diabetes involves upregulated expression of HMGB1 and can be ameliorated by inhibition of HMGB1.
authors.affiliation: Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia ; Department of Ophthalmology, King Abdulaziz University Hospital, Old Airport Road, P.O. Box 245, Riyadh 11411, Saudi Arabia.
authors.forename: Ahmed M
authors.identifier: 0000-0003-2226-8617
authors.initials: AM
authors.lastname: Abu El-Asrar
authors.affiliation: Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
authors.forename: Mohammad Mairaj
authors.initials: MM
authors.lastname: Siddiquei
authors.affiliation: Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
authors.forename: Mohd Imtiaz
authors.initials: MI
authors.lastname: Nawaz
authors.affiliation: Laboratory of Histochemistry and Cytochemistry, University of Leuven, Leuven, Belgium.
authors.forename: Karel
authors.identifier: 0000-0003-1132-1080
authors.initials: K
authors.lastname: Geboes
authors.affiliation: Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
authors.forename: Ghulam
authors.initials: G
authors.lastname: Mohammad
mesh_terms: D000818:Animals; D016207:Cytokines / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D003930:Diabetic Retinopathy / Q000378:metabolism*; D005974:Glutamate-Ammonia Ligase / Q000378:metabolism; D019695:Glycyrrhizic Acid / Q000494:pharmacology*; D024243:HMGB1 Protein / Q000037:antagonists & inhibitors / Q000378:metabolism*; D007249:Inflammation / Q000378:metabolism*; D007791:Lactoylglutathione Lyase / Q000378:metabolism; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012160:Retina / Q000187:drug effects / Q000276:immunology*; D016708:Synaptophysin / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
chemical_list: D016207:Cytokines; D024243:HMGB1 Protein; C104200:Hbp1 protein, rat; D016708:Synaptophysin; C569016:Syp protein, rat; D019695:Glycyrrhizic Acid; D014446:Tyrosine 3-Monooxygenase; D007791:Lactoylglutathione Lyase; D005974:Glutamate-Ammonia Ligase
references.citation: Eur J Neurosci. 2008 Jul;28(1):1-11
references.pmid: 18662330
references.citation: Exp Eye Res. 2013 Feb;107:101-9
references.pmid: 23261684
references.citation: J Neurochem. 2007 Oct;103(2):590-603
references.pmid: 17666052
references.citation: Diabetologia. 2012 Mar;55(3):845-54
references.pmid: 22143324
references.citation: J Neurochem. 2006 Nov;99(3):827-38
references.pmid: 16911580
references.citation: Exp Diabetes Res. 2011;2011:108328
references.pmid: 22144984
references.citation: Cytokine. 2012 Feb;57(2):210-20
references.pmid: 22154216
references.citation: Cardiovasc Pathol. 2008 May-Jun;17(3):129-38
references.pmid: 18402807
references.citation: Mediators Inflamm. 2012;2012:493043
references.pmid: 23055574
references.citation: Neurobiol Dis. 2012 Apr;46(1):147-56
references.pmid: 22266336
references.citation: Chem Biol. 2007 Apr;14(4):431-41
references.pmid: 17462578
references.citation: Neuroscience. 2001;107(1):127-42
references.pmid: 11744253
references.citation: Antioxid Redox Signal. 2011 Apr 1;14(7):1315-35
references.pmid: 20969478
references.citation: Neurochem Int. 2001 Apr;38(5):385-90
references.pmid: 11222918
references.citation: Curr Drug Targets. 2010 Nov;11(11):1468-82
references.pmid: 20583971
references.citation: Angiogenesis. 2008;11(1):91-9
references.pmid: 18264787
references.citation: FASEB J. 2004 Sep;18(12):1450-2
references.pmid: 15231732
references.citation: Diabetes. 2008 Aug;57(8):2191-8
references.pmid: 18487452
references.citation: Biochem Soc Trans. 2003 Dec;31(Pt 6):1423-5
references.pmid: 14641079
references.citation: Diabetes. 2004 Sep;53(9):2412-9
references.pmid: 15331553
references.citation: Br J Ophthalmol. 2005 Dec;89(12):1631-3
references.pmid: 16299145
references.citation: J Intern Med. 2003 Oct;254(4):375-85
references.pmid: 12974876
references.citation: Acta Pharmacol Sin. 2012 Jan;33(1):11-8
references.pmid: 22158106
references.citation: FASEB J. 2007 Dec;21(14):3904-16
references.pmid: 17628015
references.citation: Blood. 2003 Apr 1;101(7):2652-60
references.pmid: 12456506
references.citation: Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10836-41
references.pmid: 10485912
references.citation: Neurotox Res. 2011 Aug;20(2):159-69
references.pmid: 21116767
references.citation: Diabetes. 2010 Dec;59(12):3208-15
references.pmid: 20852029
references.citation: Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4281-7
references.pmid: 16249509
references.citation: Neuropharmacology. 2011 Oct-Nov;61(5-6):975-80
references.pmid: 21752338
references.citation: Mol Vis. 2011 Feb 17;17:508-18
references.pmid: 21365018
references.citation: Diabetes. 1998 May;47(5):815-20
references.pmid: 9588455
references.citation: J Cereb Blood Flow Metab. 2008 May;28(5):927-38
references.pmid: 18000511
references.citation: Exp Eye Res. 2000 Jun;70(6):723-30
references.pmid: 10843776
references.citation: Exp Eye Res. 2009 Dec;89(6):967-71
references.pmid: 19699197
references.citation: Cell Tissue Res. 2012 Apr;348(1):37-46
references.pmid: 22350850
references.citation: J Clin Invest. 1998 Mar 1;101(5):1142-7
references.pmid: 9486985
references.citation: Mol Vis. 2011;17:1829-38
references.pmid: 21850157
references.citation: Glia. 2010 Jun;58(8):1007-15
references.pmid: 20222144
references.citation: Food Chem Toxicol. 1993 Apr;31(4):303-12
references.pmid: 8386690
references.citation: Biochim Biophys Acta. 2009 Oct;1790(10):1109-16
references.pmid: 19409449
references.citation: Immunobiology. 2010 Dec;215(12):956-62
references.pmid: 20163887
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2003 Apr;27(2):283-90
references.pmid: 12657367
references.citation: Diabetologia. 2010 May;53(5):971-9
references.pmid: 20162412
references.citation: Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3143-50
references.pmid: 16799061
references.citation: Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2760-6
references.pmid: 15277502
references.citation: Brain Res. 1985 Jun 24;337(1):151-4
references.pmid: 2860952
references.citation: Int J Ophthalmol. 2010;3(2):145-8
references.pmid: 22553539
references.citation: Hum Exp Toxicol. 2012 Dec;31(12):1295-8
references.pmid: 22653692
references.citation: J Neurosci. 2011 Jan 19;31(3):1081-92
references.pmid: 21248133
references.citation: J Neurosci. 2006 Jun 14;26(24):6413-21
references.pmid: 16775128